Kyverna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-JPMORGAN CHASE & CO.(5.5%)
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Biddle Warner Weston
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Shaw Christi
Kyverna Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Biddle Warner Weston
Kyverna Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Shaw Christi
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Karen Marie
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jones Ryan Alexander
Kyverna Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Vida Ventures, LLC(11.1%),VV Manager LLC(11.1%), etc.
Kyverna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Michael P. Rubin(7.6%),Northpond Ventures III, LP(6.5%), etc.
Kyverna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(9 . 6%)
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Vida Ventures, LLC
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cohen Fred E
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SEIDENBERG BETH C
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Westlake BioPartners Fund I, L.P.
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Bain Capital Life Sciences Investors, LLC
Kyverna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Bain Capital Life Sciences Opportunities III, LP(7.4%)
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities- Northpond Ventures III GP, LLC
Kyverna Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Liapis Stephen Constantine
Kyverna Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Liapis Stephen Constantine
No Data
No Data